BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The Obesity Drug Development Summit Europe is set to be the le
 ading industry-focused event for advancing next-generation obesity therap
 ies. Taking place in Barcelona\, Spain\, from the 1st to 2nd of October 2
 025\, this inaugural summit will bring together over 50 leaders from phar
 ma\, biotech\, and academia. Attendees will address critical challenges i
 n obesity care\, including lean mass preservation\, patient stratificatio
 n\, scalable manufacturing\, and payer-driven endpoints.\n\nThis event of
 fers a unique opportunity to explore cutting-edge therapies such as GIPR 
 modulators\, DNA-encoded treatments\, and RNA-based therapies\, which aim
  to achieve metabolic transformation beyond simple weight loss. Participa
 nts will gain insights into designing clinical trials that align with pay
 er expectations by leveraging real-world evidence and precision biomarker
 s\, with contributions from industry leaders like Novo Nordisk. The summi
 t will also delve into optimizing combination therapies\, including GLP-1
 -based regimens with myostatin inhibitors and amylin analogues\, to enhan
 ce efficacy and muscle preservation.\n\nWith innovations in oral formulat
 ions and long-acting injectables from companies like Ambrosia Biosciences
  and Cytoki Pharma\, manufacturing challenges will be addressed head-on. 
 As the obesity therapeutics market evolves rapidly\, this summit is a vit
 al platform to collaborate\, benchmark\, and shape the future of obesity 
 care through precision medicine and sustainable drug development.\n\nDate
  and Time: Wednesday\, 01 October 2025 at 07:30 to Thursday\, 02 October 
 2025 at 15:30\n
DTEND:20251002T153000
DTSTAMP:20260512T232949Z
DTSTART:20251001T073000
LOCATION:Hilton Barcelona\, 589 Avinguda Diagonal\, Barcelona\, Catalunya\
 , 08014\,
SEQUENCE:0
SUMMARY:The Obesity Drug Development Summit Europe is set to be the leadin
 g industry-focused event for advancing next-generation obesity therapies.
  Taking...
UID:8114cb70-5703-41ff-aabe-c1a7474ef219
END:VEVENT
END:VCALENDAR